JP2019508455A5 - - Google Patents

Download PDF

Info

Publication number
JP2019508455A5
JP2019508455A5 JP2018548356A JP2018548356A JP2019508455A5 JP 2019508455 A5 JP2019508455 A5 JP 2019508455A5 JP 2018548356 A JP2018548356 A JP 2018548356A JP 2018548356 A JP2018548356 A JP 2018548356A JP 2019508455 A5 JP2019508455 A5 JP 2019508455A5
Authority
JP
Japan
Prior art keywords
fistula
agent according
weeks
patient
remission
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018548356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019508455A (ja
JP6931656B2 (ja
Filing date
Publication date
Priority claimed from GBGB1604304.4A external-priority patent/GB201604304D0/en
Application filed filed Critical
Publication of JP2019508455A publication Critical patent/JP2019508455A/ja
Publication of JP2019508455A5 publication Critical patent/JP2019508455A5/ja
Priority to JP2021083406A priority Critical patent/JP2021119789A/ja
Application granted granted Critical
Publication of JP6931656B2 publication Critical patent/JP6931656B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018548356A 2016-03-14 2017-03-14 クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞 Active JP6931656B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021083406A JP2021119789A (ja) 2016-03-14 2021-05-17 クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1604304.4 2016-03-14
GBGB1604304.4A GB201604304D0 (en) 2016-03-14 2016-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
PCT/IB2017/051468 WO2017158509A1 (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021083406A Division JP2021119789A (ja) 2016-03-14 2021-05-17 クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞

Publications (3)

Publication Number Publication Date
JP2019508455A JP2019508455A (ja) 2019-03-28
JP2019508455A5 true JP2019508455A5 (enExample) 2020-04-23
JP6931656B2 JP6931656B2 (ja) 2021-09-08

Family

ID=55952284

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018548356A Active JP6931656B2 (ja) 2016-03-14 2017-03-14 クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞
JP2021083406A Pending JP2021119789A (ja) 2016-03-14 2021-05-17 クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021083406A Pending JP2021119789A (ja) 2016-03-14 2021-05-17 クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞

Country Status (27)

Country Link
US (3) US10357518B2 (enExample)
EP (2) EP3219321B1 (enExample)
JP (2) JP6931656B2 (enExample)
KR (1) KR102277789B1 (enExample)
CN (2) CN115569151A (enExample)
AU (1) AU2017232718B2 (enExample)
BE (1) BE1024781B1 (enExample)
CA (1) CA3017694C (enExample)
CY (1) CY1125513T1 (enExample)
DE (1) DE102017002458B4 (enExample)
DK (1) DK3219321T3 (enExample)
ES (2) ES2911718T3 (enExample)
FR (1) FR3048614B1 (enExample)
GB (2) GB201604304D0 (enExample)
HR (1) HRP20220539T1 (enExample)
HU (1) HUE058739T2 (enExample)
IL (2) IL261730B2 (enExample)
LT (1) LT3219321T (enExample)
MX (1) MX2018010699A (enExample)
NL (1) NL2018512B1 (enExample)
NO (1) NO345415B1 (enExample)
PL (1) PL3219321T3 (enExample)
RS (1) RS63163B1 (enExample)
RU (1) RU2742308C2 (enExample)
SG (2) SG11201807404XA (enExample)
SI (1) SI3219321T1 (enExample)
WO (1) WO2017158509A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
GB201604304D0 (en) * 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
EP3601531B1 (en) 2017-03-30 2023-06-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with live biotherapeutics
AU2020228979B2 (en) * 2019-02-27 2025-05-29 Takeda Pharmaceutical Company Limited Improved stem cell populations for allogeneic therapy
CA3170915A1 (en) * 2020-03-11 2021-09-16 Mesoblast International Sarl Method for treating inflammatory bowel disease i
US20230104108A1 (en) * 2020-03-11 2023-04-06 Mesoblast International Sárl Method for treating inflammatory bowel disease ii
CN111481573A (zh) * 2020-03-26 2020-08-04 卡替(上海)生物技术股份有限公司 牙髓间充质干细胞在制备克罗恩病治疗药物中的用途
WO2022115609A1 (en) * 2020-11-25 2022-06-02 Flagship Pioneering, Inc. Adipogenic cell compositions and methods
EP4531879A1 (en) * 2022-05-25 2025-04-09 Flagship Pioneering Innovations VI, LLC Compositions of secretory and/or catalytic cells and methods using the same

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US6010696A (en) 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5733542A (en) 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
FR2680931B1 (fr) 1991-08-27 1997-08-14 Thomson Csf Procede de detection et de suivi d'objets en mouvement par analyse de sequences d'images.
BR9307550A (pt) 1992-12-02 1999-05-25 Shell Int Research Composto fungicida processo para a preparação de um composto fungicida composição fungicida processo de combate aos fungos em um local e uso
WO1995002698A1 (en) 1993-07-12 1995-01-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
US5472183A (en) 1994-03-17 1995-12-05 Nisca Corporation Sheet feeding device with multiple sheet stackers
US6174333B1 (en) 1994-06-06 2001-01-16 Osiris Therapeutics, Inc. Biomatrix for soft tissue regeneration using mesenchymal stem cells
EP0952792B1 (en) 1994-06-06 2003-08-27 Case Western Reserve University Biomatrix for tissue regeneration
EP0832271B8 (en) 1995-06-07 2005-03-02 INEX Pharmaceuticals Corp. Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US6051429A (en) 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
US6546106B2 (en) 1996-09-03 2003-04-08 New Transducers Limited Acoustic device
US5705308A (en) 1996-09-30 1998-01-06 Eastman Kodak Company Infrared-sensitive, negative-working diazonaphthoquinone imaging composition and element
AU1615599A (en) 1997-12-02 1999-06-16 Zen Bio, Inc. Differentiation of adipose stromal cells into osteoblasts and uses thereof
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US9585916B2 (en) 1999-03-26 2017-03-07 Northern Therapeutics Inc. Cell based therapy for the pulmonary system
ES2205792T3 (es) 1998-04-03 2004-05-01 Osiris Therapeutics, Inc. Celulas madre mesenquimatosas como inmunosupresores.
US6546105B1 (en) 1998-10-30 2003-04-08 Matsushita Electric Industrial Co., Ltd. Sound image localization device and sound image localization method
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20030082152A1 (en) 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
US20050153442A1 (en) 1999-03-10 2005-07-14 Adam Katz Adipose-derived stem cells and lattices
KR100979664B1 (ko) 1999-03-10 2010-09-02 유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 지방 유래 간세포 및 격자
CN1201268C (zh) 1999-06-30 2005-05-11 国际商业机器公司 实现运动模糊化的图像处理
US7670628B2 (en) 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
CA2438904C (en) 2001-02-23 2012-09-04 The University Of Pittsburgh Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
AU2002356935A1 (en) 2001-11-09 2003-05-19 Artecel Sciences, Inc. Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
CZ2004696A3 (cs) * 2001-11-09 2005-02-16 Artecel Sciences, Inc. Endokrinní pankreatická diferenciace buněk stromatu odvozených z adipózní tkáně a její použití
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
AU2003267949A1 (en) 2002-03-15 2003-12-31 U.S. Government As Represented By The Department Of Veterans Affairs Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
AU2003239016B2 (en) 2002-06-14 2007-09-20 Xintela Ab Marker for stem cells and its use
US20040101959A1 (en) 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells
DE602004029337D1 (de) 2003-04-01 2010-11-11 Us Dept Of Veteran S Affaires Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.
ES2265199B1 (es) 2003-06-12 2008-02-01 Cellerix, S.L. Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones.
CA2530421C (en) 2003-06-27 2015-04-21 Ethicon, Incorporated Repair and regeneration of ocular tissue using postpartum-derived cells
US7645229B2 (en) 2003-09-26 2010-01-12 Armstrong David N Instrument and method for endoscopic visualization and treatment of anorectal fistula
JP4749331B2 (ja) 2003-10-07 2011-08-17 株式会社バイオマスター 脂肪由来前駆細胞の細胞分化
DE602004030823D1 (de) 2003-11-04 2011-02-10 Biomaster Inc Verfahren und system zur herstellung von stammzellen aus fettgewebe
US20080095749A1 (en) 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
EP2298863B1 (en) 2004-03-22 2015-07-22 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
RU2252252C1 (ru) 2004-04-09 2005-05-20 Тепляшин Александр Сергеевич Способ выделения мезенхимальных стволовых клеток
ES2264862B8 (es) 2004-08-25 2017-01-20 Cellerix, S.L. Biomaterial para sutura.
US20060045872A1 (en) * 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
ES2313805B1 (es) 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
WO2006029347A2 (en) 2004-09-03 2006-03-16 University Of Maryland, Baltimore Integrin cd18 is a novel stromal stem cell marker and functions to promote osteogenesis
WO2006110582A1 (en) 2005-04-08 2006-10-19 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
JP5925408B2 (ja) 2005-09-23 2016-05-25 タイジェニックス、ソシエダッド、アノニマ、ウニペルソナルTigenix S.A.U. 免疫調節活性を有する細胞集団、単離方法および使用
EP1795588A1 (en) 2005-12-07 2007-06-13 Cellerix, S.L. Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
US20120269774A1 (en) 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
US20110262402A1 (en) 2007-09-07 2011-10-27 Masahiko Kuroda Therapeutic and prophylactic agents for arthritis
RU2709780C2 (ru) 2007-09-19 2019-12-20 Плуристем Лтд. Адгезивные клетки жировой ткани или плаценты и их использование в лечебных целях
ES2595103T3 (es) 2007-10-17 2016-12-27 Txcell Células Tr1, células madre mesenquimales y usos de estas
GB0814249D0 (en) 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
ES2345867B1 (es) * 2009-04-03 2011-07-28 Fundacion Instituto Mediterraneo Para La Biotecnologia Y La Investigacion Sanitaria (Imabis) Celulas madre multipotentes derivadas de estroma de mesenterio.
WO2010126194A1 (ko) * 2009-04-28 2010-11-04 (주) 안트로젠 누공 치료를 위한 자가 및 동종의 지방 유래 스트로마 줄기세포 조성물
BR112012000534A2 (pt) 2009-07-09 2017-06-13 Cellerix Sa métodos e composições para uso em terapias celulares
CN103298939A (zh) * 2010-12-06 2013-09-11 夸克医药公司 包含位置修饰的双链寡核苷酸化合物
WO2012095743A2 (en) 2011-01-12 2012-07-19 Cellerix Sa Methods and compositions for use in intralymphatic cellular therapies
ES2479565T1 (es) 2011-03-11 2014-08-20 Tigenix, S.A.U. Poblaciones celulares que tienen actividad immunoreguladora, método para el aislamiento y usos
US20140134140A1 (en) 2012-11-09 2014-05-15 Case Western Reserve University Mesenchymal stem cell compositions for the treatment of microbial infections
CA2906299C (en) * 2013-03-15 2023-04-04 Tigenix, S.A.U Lymphocyte biomarkers for determining the clinical response to cell therapy
US20160120910A1 (en) 2013-06-25 2016-05-05 Tigenix S.A.U. Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
CA2953884C (en) * 2014-06-30 2022-12-06 Tigenix S.A.U. Mesenchymal stromal cells for treating sepsis
AU2016327285A1 (en) * 2015-09-24 2018-04-12 Cellect Biotherapeutics Ltd. Methods for propagating mesenchymal stem cells (MSC) for use in transplantation
GB201604304D0 (en) * 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
US10152822B2 (en) 2017-04-01 2018-12-11 Intel Corporation Motion biased foveated renderer
US10890966B2 (en) 2017-07-27 2021-01-12 Arm Limited Graphics processing systems
US10818080B2 (en) 2018-07-25 2020-10-27 Disney Enterprises, Inc. Piecewise-polynomial coupling layers for warp-predicting neural networks
US11109065B2 (en) 2018-09-26 2021-08-31 Google Llc Video encoding by providing geometric proxies

Similar Documents

Publication Publication Date Title
JP2019508455A5 (enExample)
JP2021119789A5 (enExample)
Maumus et al. Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes
Mei et al. Advances and clinical challenges of mesenchymal stem cell therapy
Xu et al. Circulating mesenchymal stem cells and their clinical implications
Wu et al. Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model
US8562973B2 (en) Treatment of sarcoidosis using placental stem cells
CA2732908C (en) Uses of mesenchymal stem cells
RU2018131519A (ru) Стромальные стволовые клетки жировой ткани для использования в лечении рефракторных сложных перианальных фистул при болезни крона
He et al. Injection of Sca-1+/CD45+/CD31+ mouse bone mesenchymal stromal-like cells improves cardiac function in a mouse myocardial infarct model
Huang et al. Updates on GMSCs treatment for autoimmune diseases
Wobma et al. Mesenchymal stromal cells: Getting ready for clinical primetime
Grabowska et al. Myogenic potential of mesenchymal stem cells-the case of adhesive fraction of human umbilical cord blood cells
CN111212654A (zh) 用激活的调节性t细胞治疗肝衰竭
JP2017520582A5 (enExample)
Chen et al. Current state of heart failure treatment: are mesenchymal stem cells and their exosomes a future therapy?
ES2742035T3 (es) Tratamiento de las enfermedades de la disfunción y la inflamación endotelial
KR101774751B1 (ko) Il-17 산생 억제 조성물
CN106581763A (zh) 一种干细胞人微型器官的制备方法
Hsu et al. Challenges and Perspectives on the Use of Pericytes in Tissue Engineering
Ishii Stem Cell Therapy and Regenerative
Carvalho et al. UM171 EXPANDS IMMATURE BONE MARROW CD34+ CELLS FROM PATIENTS WITH TELOMEROPATHIES
Alexandrova et al. Actin cytoskeleton reorganization in bone marrow multipotent mesenchymal stromal cells at the initial step of transendothelial migration
Li et al. 253. The Use of Osteoporotic BMSCs Engineered by Baculovirus-Mediated MicroRNAs Sponge to Heal Osteoporotic Bone Defect
AU2015268704B2 (en) Uses of mesenchymal stem cells